A citation-based method for searching scientific literature

Rong Na, S Lilly Zheng, Misop Han, Hongjie Yu, Deke Jiang, Sameep Shah, Charles M Ewing, Liti Zhang, Kristian Novakovic, Jacqueline Petkewicz, Kamalakar Gulukota, Donald L Helseth, Margo Quinn, Elizabeth Humphries, Kathleen E Wiley, Sarah D Isaacs, Yishuo Wu, Xu Liu, Ning Zhang, Chi-Hsiung Wang, Janardan Khandekar, Peter J Hulick, Daniel H Shevrin, Kathleen A Cooney, Zhoujun Shen, Alan W Partin, H Ballentine Carter, Michael A Carducci, Mario A Eisenberger, Sam R Denmeade, Michael McGuire, Patrick C Walsh, Brian T Helfand, Charles B Brendler, Qiang Ding, Jianfeng Xu, William B Isaacs. Eur Urol 2017
Times Cited: 189



Emmanuel S Antonarakis, Changxue Lu, Brandon Luber, Chao Liang, Hao Wang, Yan Chen, John L Silberstein, Danilo Piana, Zhao Lai, Yidong Chen, William B Isaacs, Jun Luo. Eur Urol 2018
Times Cited: 108




List of shared articles



Times cited

Implications of DNA damage repair alterations for the management of prostate cancer.
Rebeca Lozano, David Olmos, Elena Castro. Curr Opin Urol 2022
0

PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer.
Ronan Flippot, Anna Patrikidou, Mihaela Aldea, Emeline Colomba, Pernelle Lavaud, Laurence Albigès, Natacha Naoun, Pierre Blanchard, Mario Terlizzi, Camilo Garcia,[...]. Drugs 2022
0

Germline genetics of prostate cancer.
Hiba M Khan, Heather H Cheng. Prostate 2022
0

The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
Jonathan I Epstein, Mahul B Amin, Samson W Fine, Ferran Algaba, Manju Aron, Dilek E Baydar, Antonio Lopez Beltran, Fadi Brimo, John C Cheville, Maurizio Colecchia,[...]. Arch Pathol Lab Med 2021
61

Prevalence of comprehensive DNA damage repair gene germline mutations in Chinese prostate cancer patients.
Junlong Wu, Yu Wei, Jian Pan, Shengming Jin, Weijie Gu, Hualei Gan, Yao Zhu, Ding-Wei Ye. Int J Cancer 2021
4

Genetic counseling in prostate cancer: How to implement it in daily clinical practice?
A Borque-Fernando, R Espílez, D Miramar, D Corbatón, A Rodríguez, E Castro, J Mateo, L Rello, A Méndez, M J Gil Sanz. Actas Urol Esp (Engl Ed) 2021
0

New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer.
Vincenza Conteduca, Alessandra Mosca, Nicole Brighi, Ugo de Giorgi, Pasquale Rescigno. Cells 2021
9

Olaparib for the treatment of metastatic prostate cancer.
Corinne Maurice Dror, Alexander W Wyatt, Kim N Chi. Future Oncol 2021
0

Prostate cancer and PARP inhibitors: progress and challenges.
Diego Teyssonneau, Henri Margot, Mathilde Cabart, Mylène Anonnay, Paul Sargos, Nam-Son Vuong, Isabelle Soubeyran, Nicolas Sevenet, Guilhem Roubaud. J Hematol Oncol 2021
19

Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention.
Maria Teresa Vietri, Giovanna D'Elia, Gemma Caliendo, Marianna Resse, Amelia Casamassimi, Luana Passariello, Luisa Albanese, Michele Cioffi, Anna Maria Molinari. Int J Mol Sci 2021
10

Basic Science and Molecular Genetics of Prostate Cancer Aggressiveness.
Matthew J Schiewer, Karen E Knudsen. Urol Clin North Am 2021
3

Genetic Contribution to Metastatic Prostate Cancer.
Alexandra O Sokolova, Elias I Obeid, Heather H Cheng. Urol Clin North Am 2021
0


Role of the DNA damage response in prostate cancer formation, progression and treatment.
Wenhao Zhang, Dik C van Gent, Luca Incrocci, Wytske M van Weerden, Julie Nonnekens. Prostate Cancer Prostatic Dis 2020
12


Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer.
Yishuo Wu, Hongjie Yu, Shuwei Li, Kathleen Wiley, S Lilly Zheng, Holly LaDuca, Marta Gielzak, Rong Na, Brice A J Sarver, Brian T Helfand,[...]. Eur Urol Oncol 2020
24

Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer.
Tamara L Lotan, Scott A Tomlins, Tarek A Bismar, Theodorus H Van der Kwast, David Grignon, Lars Egevad, Glen Kristiansen, Colin C Pritchard, Mark A Rubin, Lukas Bubendorf. Am J Surg Pathol 2020
20

Therapeutic targeting of the DNA damage response in prostate cancer.
Catherine H Marshall, Emmanuel S Antonarakis. Curr Opin Oncol 2020
7

Prognostic Value of Germline DNA Repair Gene Mutations in De Novo Metastatic and Castration-Sensitive Prostate Cancer.
Yu Wei, Junlong Wu, Weijie Gu, Jun Wang, Guowen Lin, Xiaojian Qin, Bo Dai, Hualei Gan, Dingwei Ye, Yao Zhu. Oncologist 2020
13